NOW Foods B-12 Sublingual targets people who need vitamin B12 but may have impaired gastrointestinal absorption. Sublingual delivery places B12 under the tongue to allow mucosal uptake as an alternative to standard oral capsules or intramuscular (IM) injections. Given that up to 40–50% of the U.S. population shows low B12 in some analyses and that people with hypothyroidism may have deficiency rates approaching 50%, a non-oral route is a sensible option for many patients and clinicians.
This review is based on synthesis of clinical and consumer-facing material in the research brief: a clinical overview and patient guidance (Cleveland Clinic), a systematic review and network meta-analysis comparing oral, IM and sublingual routes (PMC), a clinical commentary noting advantages of sublingual and IM routes for some patients (RestartMed), a safety/side-effect summary (GHS Agenda), and a consumer-testing perspective on whether sublingual is meaningfully better than pills (ConsumerLab).
High-level verdict: NOW Foods’ sublingual delivers the expected practical benefit of a buccal-route B12 — useful for people on acid-suppressing drugs, with GI malabsorption, hypothyroidism-related risk, or those who dislike injections. Strengths are convenience and generally low side-effect risk; weaknesses are that the literature does not uniformly prove sublingual superiority over high-dose oral regimens, and severe deficiency/pernicious anemia still often requires IM therapy.
Does sublingual B12 improve absorption compared with pills or shots?
Sublingual delivery bypasses some gastrointestinal absorption steps and is presented in the clinical commentary as an alternative to intramuscular injections for patients with impaired gut uptake. The systematic review in the brief specifically evaluated oral, intramuscular (IM), and sublingual (SL) routes, reflecting active debate and comparison in the literature.
That said, the evidence is mixed: the review compared routes but did not produce a definitive clinical consensus that SL is always superior to high-dose oral therapy. RestartMed notes sublingual and IM can be superior to standard oral forms in patients taking acid-blocking medications (PPIs, H2 blockers) or with other malabsorption risks.
Is sublingual B12 safe and well tolerated?
Across consumer and clinical summaries in the brief, sublingual B12 is described as generally safe with rare, mild side effects. The GHS Agenda guidance characterizes side effects as uncommon and lightweight; Cleveland Clinic lists standard medication warnings (e.g., Leber's disease, iron or folate deficiency, allergies, pregnancy/breastfeeding) and advises discussing medical history with a provider.
A commonly reported mild effect in lay sources is increased appetite in some people who are correcting deficiency; the brief flags this as a possible outcome of restoring B12 in deficient individuals rather than a direct pharmacologic adverse effect.
Who benefits most from a sublingual B12?
Sublingual B12 is most relevant for people with documented or suspected poor GI absorption: those on proton pump inhibitors or H2 blockers, people taking certain common non-steroidal anti-inflammatory drugs that may interfere with absorption, patients with hypothyroidism (where deficiency prevalence may approach 50%), and people with methylation pathway variants (noted in the brief as common, up to ~40% in some cohorts).
For routine dietary supplementation in people without absorption risk, the systematic review and ConsumerLab summary indicate that high-dose oral B12 pills can be effective, so sublingual is not strictly necessary for everyone.
How does sublingual compare to IM injections and oral tablets?
RestartMed and Cleveland Clinic both position sublingual and IM routes as preferred when absorption is a concern. The network meta-analysis cited in the brief evaluated oral, SL and IM routes to compare efficacy, reflecting ongoing research interest.
However, the literature summarized in ConsumerLab and the systematic review shows mixed results: IM injections remain the fastest way to replete severe deficiency; sublingual offers a non-invasive middle ground, and high-dose oral regimens can sometimes match outcomes in people without absorption defects.
How to know if you need it and how to monitor
The brief emphasizes that serum B12 alone is an imperfect marker of cellular B12 status and that standard lab ranges may miss subclinical deficiency. Providers often use additional markers or clinical context (symptoms, methylmalonic acid, homocysteine) to assess the need for replacement.
If you begin sublingual B12 because of risk factors (acid blockers, hypothyroidism), discuss baseline testing and follow-up with your clinician; severe deficiency or pernicious anemia often requires parenteral therapy and closer monitoring.
Pros & Cons
- ✅ Bypasses some GI absorption steps — useful for patients on proton pump inhibitors or H2 blockers (research brief notes acid/H2 blockers can impede B12 uptake).
- ✅ Non-invasive alternative to intramuscular injections for many patients with malabsorption risk (RestartMed, Cleveland Clinic).
- ✅ Generally well tolerated; side effects described as rare and mild in consumer/clinical summaries (GHS Agenda).
- ✅ Practical for people who dislike needles or need outpatient daily dosing instead of clinic-based IM shots.
- ✅ Relevant in populations with high prevalence of low B12: up to 40–50% in some U.S. analyses and higher in hypothyroid patients (~50%) according to the brief.
- ❌ Evidence of clear superiority over high-dose oral B12 is mixed — systematic review and ConsumerLab summaries do not uniformly favor SL over oral tablets.
- ❌ Not the fastest option for severe deficiency or pernicious anemia, where IM injections are often preferred.
- ❌ Possible mild effects such as increased appetite reported when correcting deficiency (GHS Agenda); requires clinician oversight in certain conditions (e.g., Leber's disease, low iron/folate, pregnancy).
- ❌ Serum B12 value alone can be misleading; monitoring and interpretation may require additional tests (methylmalonic acid/homocysteine) per clinical guidance.
How It Compares to the Competition
- Jarrow Formulas Methyl B-12 Lozenges — Similar sublingual lozenge format often sold as methylcobalamin rather than generic cobalamin; positioned for people seeking a methylated form.
- Garden of Life mykind Organics B12 — Whole-food-based sublingual option marketed for users seeking organic/food-derived vitamin sources.
- Solgar Vitamin B12 Lozenge — Longstanding supplement brand offering lozenges; competes on formulation variety and retail availability.
- Nature's Bounty B12 Sublingual — Widely distributed sublingual option with similar use case; often chosen by shoppers looking for broad retail availability.
Who Should Buy This & Who Should Skip It
Buy it if: Buy if you have confirmed or suspected poor oral absorption (on acid blockers, H2 blockers, or with GI malabsorption), have hypothyroidism and possible low B12, dislike injections, or need a daily non-invasive replacement option. Also reasonable for people advised by clinicians to use a mucosal route but who do not require immediate parenteral repletion.
Skip it if: Skip if you have confirmed severe B12 deficiency or pernicious anemia that your clinician wants to treat with intramuscular injections, or if you are being adequately repleted with high-dose oral therapy and have no absorption risk. Also avoid without medical advice if you have Leber's disease, active folate/iron deficiency concerns, or known allergies noted in clinical guidance.
Search Purchase Options
Use these links to search for NOW Foods B-12 Sublingual on trusted marketplaces. The links open in new tabs; if you buy through them, we may earn a commission at no extra cost to you.
* Affiliate links: you pay the same price either way.